International Journal of Biomedicine. 2019;9(1):19-22.
Originally published March 15, 2019
The objective of this study was to analyze the psychophysiological personality characteristics of male survivors of MI in order to identify the risks of recurrent cardiovascular events.
Material and Methods: We observed 60 male patients (mean age of 46.5 [38.7; 54.3]) diagnosed with IHD during outpatient and inpatient treatment. In the past (from one to three years ago), all of them suffered Q-wave MI (75% - with localization in the posterior wall of the left ventricle, 25% - in the anteroseptal area). The psychological study included the following techniques and methods: the abridged MMMPI, the Spielberger-Khanin test, the TAS in the variant modified at V.M. Bekhterev Research Institute, S. Subbotin's STQ, E. Heim's technique for revealing individual coping strategies, and the projective psycho-geometric test.
Results: The discovered characteristics applicable to the psychological portrait of males with a history of MI (elevated levels of neuroticism and anxiety with elements of demonstrative behavior, complications in the expression of feelings and emotions) are a reflection of the psychosomatic radical component of IHD. This finding enables us to recommend including methods of psychological correction of discovered intrapersonal changes in the measures for preventing recurrent cardiovascular events in the studied cohort of patients.
- The Demographic Yearbook of Russia. Stat. sb. Rosstat, Moscow; 2015. ISBN 978-5-8947 6-414-6. [In Russian].
- Boĭtsov SA, Samorodskaia IV. [Dynamics of cardiovascular mortality among men and women in subjects of Russian Federation (2002 to 2011)]. Kardiologiia. 2014;54(4):4-9.[Article in Russian]
- Boytsov SA, Deev AD, Shalnova SA. [Mortality and risk factors for non-communicable diseases in Russia: Specific features, trends, and prognosis]. Ter Arkh. 2017;89(1):5-13. doi: 10.17116/terarkh20178915-13. [Article in Russian].
- Ageenkova E.K. Arbitrary prolongation of psycho-emotional stress as a risk factor for cardiovascular diseases) [Electronic publication]. Personality in a Changing World: Health, Adaptation, Development. 2016, 4 (15). [Article in Russian].
- Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol. 2009 Mar 17;53(11):936-46. doi: 10.1016/j.jacc.2008.11.044.
- Isaeva ER. Coping behavior and psychological protection of the individual in the health and illness conditions). SPb GMU; 2009. ISBN 978-5-88999-069-7 [In Russian].
- Zaitsev VP. Mini-Mult psychological test version. Psikhologicheskiy Zhurnal. 1981;2(3): 118-123. (in Russian)
- Zaĭtsev VP, Aĭvazian TA. [Psychological AMPI test: application in clinical medicine (analytical review)]. Ter Arkh. 2008;80(4):89-92. [Article in Russian].
- Karandashev VN, Lebedev MS, Spielberger CD. Evaluation of anxiety: a guide to use. St. Petersburg; 2004. [In Russia].
- Khanin YL. A brief guide to the use of a scale of reactive and personal anxiety by Ch.D. Spielberger. Leningrad.: LNII FC; 1976. [In Russia].
- Isurina GL, Kaydanovskaya EV, Karvasarsky BD. Alexithymia and methods of determination thereof in allied psychosomatic disorders: Method, textbook, St. Petersburg; 1994. [In Russian].
- Heim E. [Coping and psychological adaptation: is there appropriate and inappropriate coping?].Psychother Psychosom Med Psychol. 1988;38(1):8-18.[Article in German].
- Karademas EC, Tsalikou C, Tallarou MC. The impact of emotion regulation and illness-focused copying strategies on the relationship of illness-related negative emotions to subjective health. J Health Psychol. 2011;16(3):510-9. doi: 10.1177/1359105310392093.
- Dellinger S. Psychogeomtrics. Psychogeomtrics: How to Use Geometric Psychology to Influence People. New Jersey: Prentice-Hall; 1989.
- Smulevich AB. Psychosomatic disorders in clinical practice. In: Smulevich AB, editor. MEDpress-inform, Moscow; 2016. ISBN 978-5-00030-295-8. [In Russian].
Received November 26, 2018.
Accepted January 18, 2019.
©2019 International Medical Research and Development Corporation.